The Effect of Renal Replacement Therapies on Serum Gastrointestinal System Hormones

REFERENCES

• Aguilera A, Bajo MA, et al. Gastrointestinal and pancreatic function in peritoneal dialysis patients: Their relationship with malnutrition and peritoneal membrane abnormalities. Am J Kidney Dis. 2003; 42: 787–796
   PubMed Web of Science ®Google Scholar
• Kang JY. The gastrointestinal tract in uremia. Dig Dis Sci. 1993; 38: 257–268
   PubMed Web of Science ®Google Scholar
• Magnusson M, Magnusson KE, Sundqvist T, Denneberg T. Increased intestinal permeability to differently sized polyethylene glycols in uremic rats: Effects of low- and high-protein diets. Nephron. 1990; 56: 306–311
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Dure-Smith B, Miller R, Mirahmadi MK. Pathology of gastrointestinal tract in chronic hemodialysis patients: An autopsy study of 78 cases. Am J Gastroenterol. 1985; 80: 608–611
   PubMed Web of Science ®Google Scholar
• Sirinek KR, O'Dorisio TM, Gaskill HV, Levine BA. Chronic renal failure: Effect of hemodialysis on gastrointestinal hormones. Am J Surg. 1984; 148: 732–735
   PubMed Web of Science ®Google Scholar
• Suda K, Ariwa R. The islets of Langerhans in uremic patients receiving chronic hemodialysis. Nephron. 1987; 46: 134–136
   PubMedGoogle Scholar
• Hegbrant J, Thysell H, Ekman R. Plasma levels of gastrointestinal regulatory peptides in patients receiving maintenance hemodialysis. Scand J Gastroenterol. 1991; 26: 599–604
   PubMed Web of Science ®Google Scholar
• Katz AI, Emmanouel DS. Metabolism of polypeptide hormones by the normal kidney and in uremia. Nephron. 1978; 22: 69–80
   PubMedGoogle Scholar
• Honda K, Nitta K, Horita S, Yumura W, Nihei H. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron. 1996; 72: 171–176
   PubMedGoogle Scholar
• Owyang C, Miller LJ, DiMagno EP, Brennan LA, Jr., Go VL. Gastrointestinal hormone profile in renal insufficiency. Mayo Clin Proc. 1979; 54: 769–773
   PubMed Web of Science ®Google Scholar
• Owyang C, Miller LJ, DiMagno EP, Mitchell JC, III, Go VL. Pancreatic exocrine function in severe human chronic renal failure. Gut. 1982; 23: 357–361
   PubMed Web of Science ®Google Scholar
• Piga M, Altieri P, Floris A, et al. Vasoactive intestinal polypeptide (VIP) plasma levels in chronic renal failure. J Nucl Med Allied Sci. 1984; 28: 77–80
   Google Scholar
• Malyszko J, Sosnowski S, Mazerska M, et al. Gastric and pancreatic functions in haemodialyzed patients. Int Urol Nephrol. 1995; 27: 471–478
   PubMedGoogle Scholar
• Aguilera A, Codoceo R, Selgas R, et al. Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: Their relationship with nutritional parameters. Nephrol Dial Transplant. 1998; 13: 1476–1483
   Google Scholar
• Falcao HA, Wesdorp RI, Fischer JE. Gastrin levels and gastric acid secretion in anephric patients and in patients with chronic and acute renal failure. J Surg Res. 1975; 18: 107–111
   PubMedGoogle Scholar
• O'Dorisio TM, Sirinek KR, Mazzaferri EL, Cataland S. Renal effects on serum gastric inhibitory polypeptide (GIP). Metabolism. 1977; 26: 651–656
   PubMed Web of Science ®Google Scholar
• Ravelli AM. Gastrointestinal function in chronic renal failure. Pediatr Nephrol. 1995; 9: 756–762
   PubMedGoogle Scholar
• Wright M, Woodrow G, O'Brien S, et al. Cholecystokinin and leptin: Their influence upon the eating behaviour and nutrient intake of dialysis patients. Nephrol Dial Transplant. 2004; 19: 133–140
   PubMed Web of Science ®Google Scholar
• Nakahama H, Tanaka Y, Shirai D, et al. Elevated serum pepsinogens in chronic renal failure patients. Nephron. 1995; 70: 211–216
   Google Scholar
• Sosnowski S, Megraud F, Mitwali A, Rabinovich S, Oreopolos DG. Autopsy findings in patients treated by continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull. 1986; 6: 130–135
   Google Scholar
• Pannekeet MM, Krediet RT, Boeschoten EW, Arisz L. Acute pancreatitis during CAPD in The Netherlands. Nephrol Dial Transplant. 1993; 8: 1376–1381
   Google Scholar
• Singh S, Wadhwa N. Peritonitis, pancreatitis, and infected pseudocyst in a continuous ambulatory peritoneal dialysis patient. Am J Kidney Dis. 1987; 9: 84–86
   Google Scholar
• Caruana RJ, Wolfman NT, Karstaedt N, Wilson DJ. Pancreatitis: An important cause of abdominal symptoms in patients on peritoneal dialysis. Am J Kidney Dis. 1986; 7: 135–140
   Google Scholar
• Masoero G, Bruno M, Gallo L, Colaferro S, Cosseddu D, Vacha GM. Increased serum pancreatic enzymes in uremia: Relation with treatment modality and pancreatic involvement. Pancreas. 1996; 13: 350–355
   PubMed Web of Science ®Google Scholar
• Rutsky EA, Robards M, Van Dyke JA, Rostand SG. Acute pancreatitis in patients with end-stage renal disease without transplantation. Arch Intern Med. 1986; 146: 1741–1745
   PubMedGoogle Scholar
• Gupta A, Yuan ZY, Balaskas EV, Khanna R, Oreopoulos DG. CAPD and pancreatitis: No connection. Perit Dial Int. 1992; 12: 309–316
   PubMed Web of Science ®Google Scholar
• Caruana RJ, Burkart J, Segraves D, Smallwood S, Haymore J, Disher B. Serum and peritoneal fluid amylase levels in CAPD. Normal values and clinical usefulness. Am J Nephrol. 1987; 7: 169–172
   Google Scholar
• Burkart J, Haigler S, Caruana R, Hylander B. Usefulness of peritoneal fluid amylase levels in the differential diagnosis of peritonitis in peritoneal dialysis patients. J Am Soc Nephrol. 1991; 1: 1186–1190
   Google Scholar
• Kimmel PL, Tenner S, Habwe VQ, Henry J, Lakshminarayan S, Steinberg W. Trypsinogen and other pancreatic enzymes in patients with renal disease: A comparison of high-efficiency hemodialysis and continuous ambulatory peritoneal dialysis. Pancreas. 1995; 10: 325–330
   Google Scholar
• Lasson A, Borgstrom A, Ohlsson K. Elevated pancreatic secretory trypsin inhibitor levels during severe inflammatory disease, renal insufficiency, and after various surgical procedures. Scand J Gastroenterol. 1986; 21: 1275–1280
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Majumdar AP, Dubick MA, Vesenka GD, Mar G, Geokas MC. Biochemical changes in the pancreas of rats with chronic renal failure. Am J Physiol. 1985; 249(4 Pt 2)F518–F523
   Google Scholar
• Geokas MC, Reidelberger R, O'Rourke M, Passaro E, Jr, Largman C. Plasma pancreatic trypsinogens in chronic renal failure and after nephrectomy. Am J Physiol. 1982; 242: G177–G182
   PubMed Web of Science ®Google Scholar
• Shepherd AM, Stewart WK, Wormsley KG. Peptic ulceration in chronic renal failure. Lancet. 1973; 1: 1357–1359
   PubMed Web of Science ®Google Scholar
• Hallgren R, Landelius J, Fjellstrom KE, Lundqvist G. Gastric acid secretion in uraemia and circulating levels of gastrin, somatostatin, and pancreatic polypeptide. Gut. 1979; 20: 763–768
   PubMedGoogle Scholar
• Taylor IL, Sells RA, McConnell RB, Dockray GJ. Serum gastrin in patients with chronic renal failure. Gut. 1980; 21: 1062–1067
   PubMed Web of Science ®Google Scholar
• Hallgren R, Karlsson FA, Lundqvist G. Serum level of immunoreactive gastrin: Influence of kidney function. Gut. 1978; 19: 207–213
   PubMed Web of Science ®Google Scholar
• Gur G, Boyacioglu S, Gul C, et al. Impact of Helicobacter pylori infection on serum gastrin in haemodialysis patients. Nephrol Dial Transplant. 1999; 14: 2688–2691
   Google Scholar
• Kamata K, Uchida M, Takeuchi Y, et al. Increased serum concentrations of pro-gastrin-releasing peptide in patients with renal dysfunction. Nephrol Dial Transplant. 1996; 11: 1267–1270
   PubMedGoogle Scholar
• Paimela H, Harkonen M, Karonen SL, Tallgren LG, Ahonen J. The effect of renal transplantation on gastric acid secretion and on the serum levels of gastrin and group I pepsinogens. Ann Clin Res. 1985; 17: 105–109
   Google Scholar